Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dynavax

10.24
+0.29002.91%
Post-market: 10.240.00000.00%19:09 EDT
Volume:1.41M
Turnover:14.32M
Market Cap:1.23B
PE:-21.83
High:10.25
Open:10.09
Low:10.00
Close:9.95
Loading ...

Goldman Sachs Downgrades Dynavax Technologies to Sell From Neutral, Adjusts Price Target to $12 From $15

MT Newswires Live
·
11 Feb

Dynavax downgraded to Sell from Neutral at Goldman Sachs

TIPRANKS
·
11 Feb

Dynavax Announces Leadership Transition Following Resignation

TIPRANKS
·
08 Feb

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

PR Newswire
·
07 Feb

Dynavax Announces New Board Appointments and Adjustments

TIPRANKS
·
30 Jan

Dynavax Technologies Corp expected to post earnings of 4 cents a share - Earnings Preview

Reuters
·
29 Jan

Press Release: Dynavax Advances Board Refreshment Program

Dow Jones
·
27 Jan

Dynavax Technologies (DVAX) Upgraded to Buy: Here's What You Should Know

Zacks
·
17 Jan

Dynavax Reports Revenue Growth and Defense Contract

TipRanks
·
14 Jan

Dynavax price target raised to $31 from $29 at H.C. Wainwright

TIPRANKS
·
14 Jan

Dynavax Technologies Corporation : H.c. Wainwright Raises Target Price to $31 From $29

THOMSON REUTERS
·
14 Jan

Strong Market Position and Growth Potential Drive Buy Rating for Dynavax

TIPRANKS
·
14 Jan

Dynavax (DVAX) Receives a Buy from JMP Securities

TIPRANKS
·
14 Jan

Dynavax sees Q4 HEPLISAV-B revenue $71M

TIPRANKS
·
13 Jan

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

THOMSON REUTERS
·
13 Jan

Dynavax Technologies Corp: Heplisav-B Quarterly Net Product Revenue of $71 Mln

THOMSON REUTERS
·
13 Jan

Press Release: Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Dow Jones
·
13 Jan

Implied Volatility Surging for Dynavax Technologies (DVAX) Stock Options

Zacks
·
03 Jan